The evolution of data architecture is accelerating. In 2025, 85% of DBTA subscribers reported plans to modernize their data platforms—driven largely by the explosive rise of GenAI and large language ...
This database originally covered cases from 1982 to 2012 and has since been updated and expanded numerous times. For analysis and context on this data—including how we built the database, and a change ...
In a press release issued on Tuesday, Genevant Sciences and Arbutus Biopharma announced they have entered into a global settlement with Moderna, Inc. that could result in a payment of up to $2.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results